1.      Ke-Bin Huang+, Feng-Yang Wang+, Yuan Lu+, Liang-Mei Yang, Nian Long,Shan-Shan Wang, Zhiying Xie, Matthew Levinec, Taotao Zou*, Jonathan L. Sessler*,Hong Liang*. Cu(II) complex thatsynergistically potentiates cytotoxicity and an antitumor immune response bytargeting cellular redox homeostasis. PNAS, 2024, 121(24), e2404668121.

2.      Peijing Xu+, Changchun Wen+, Cunji Gao*, Huihui Liu, Yingshu Li, Xiaolu Guo,Xing-Can Shen*, Hong Liang*. Near-Infrared-II-ActivatableSelf-Assembled Manganese Porphyrin-Gold Heterostructures for PhotoacousticImaging-Guided Sonodynamic-Augmented Photothermal/Photodynamic Therapy. ACSNano, 2024, 18, 713−727.

3.      Yulong Bai+, JingHua+, Jingjin Zhao*, Shulong Wang, Mengjiao Huang, Yang Wang, YanniLuo, Shulin Zhao*, Hong Liang*. ASilver-Induced Absorption Red-Shifted Dual-Targeted Nanodiagnosis-TreatmentAgent for NIR-II Photoacoustic Imaging-Guided Photothermal and ROSSimultaneously Enhanced Immune Checkpoint Blockade Antitumor Therapy. AdvanceScience, 2023, 2306375.

4.      Qi-Yuan Yang+, Rui Ma+, Yun-Qiong Gu+, Xiao-Fang Xu, Zhen-Feng Chen*, Hong Liang*. Arene-Ruthenium(II)/Osmium(II) ComplexesPotentiate the Anticancer Efficacy of Metformin via Glucose MetabolismReprogramming. Angew. Chem. Int. Ed., 2022, e202208570.

5.      Xiaolin Xiong+, Ke-Bin Huang+, Yuan Wang+, Bei Cao, Yunli Luo, HuowenChen, Yan Yang, Yan Long, Moyi Liu, Albert S. C. Chan, Hong Liang*, Taotao Zou*. Target Profiling of an Iridium(III)-BasedImmunogenic Cell Death Inducer Unveils the Engagement of Unfolded ProteinResponse Regulator BiP. J. Am.Chem. Soc., 2022, 144, 23, 10407–10416.

6.      Yan-Lei Ma*, Ji-PingYue*, Yao Zhang*, Chen-Zhang Shi*, Matt Odenwald, Wenguang G. Liang, Qing Wei,Ajay Goel, Xue-Wen Gou, Jamie Zhang, Shao-Yu Chen, Wei-Jen Tang, Jerrold R.Turner, Feng Yang, Hong Liang*,Huan-Long Qin, Xiao-Yang Wu. ACF7 regulates inflammatory colitis and intestinalwound response by orchestrating tight junction dynamics. Nat. Commun. 2017, 8, 15375.

7.      Ji-Ping Yue, YaoZhang, Wen-Guang G. Liang, Xue-Wen Gou, Philbert Lee, Han Liu, Wan-Qing Lyu,Wei-Jen Tang, Shao-Yu Chen, Feng Yang*, HongLiang*, Xiao-Yang Wu*. In Vivo Epidermal Migration Requires FocalAdhesion Targeting of ACF7. Nat.Commun. 2016, 7, 11692.

8.       Yi Gou, GuoJin Huang , Jinlong Li, Feng Yang*, Hong Liang*. Versatiledelivery systems for non-platinum metal-based anticancer therapeutic agents, Coordin. Chem. Rev., 2021, 441, 213975.

9.      Wenjuan Li, Shanhe Li,Zhenlei Zhang, Gang Xu, Xueyu Man, Feng Yang*, Hong Liang*. Developing aMultitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue inthe IIA Subdomain of Human Serum Albumin. J.Med. Chem.,2023, 66, 8564–8579.

10.   Xing Lu, Mei-Feng Wu, Jiang-LunWu, Hai-Qun Zhang, Hong Liang*, Zhen-Feng Chen*. Platinum-Based Mcl‑1 Inhibitor TargetingMitochondria Achieves Enhanced Antitumor Activity as a Single Agent or inCombination  with ABT-199.J. Med. Chem., 2023, 66, 8705−8716.

11.   Zhenlei Zhang†, Juzheng Zhang†,Tongfu Yang†, Shanhe Li, Gang Xu, Hong Liang*, Feng Yang*. Developing an Anticancer Platinum(II) Compound Basedon the Uniqueness of Human Serum Albumin. J.Med. Chem., 2023, 66， 5669−5684.

12.   Xueyu Man§, Tongfu Yang§,Wenjuan Li, Shanhe Li, Gang Xu, Zhenlei Zhang, Hong Liang*, Feng Yang*. Developing a Gadolinium(III) Compound Based onApoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy ofCancer. J. Med. Chem., 2023, 66, 7268−7279.

13.   Tongfu Yang, Zhenlei Zhang,Juzheng Zhang, Yanping Li, Wenjuan Li, Hong Liang*, Feng Yang*. Developing a Gallium(III) Agent Based on theProperties of the Tumor Microenvironment and Lactoferrin: Achieving Two-AgentCo-delivery and Multi-targeted Combination Therapy of Cancer. J. Med. Chem., 2023, 66， 793−803.

14.    Shuang Kan, Rong Li, Yanhui Tan, Fang Yang, Shaohua Xu, Lingzhu Wang, Lijun Zhang, Xuchen Sun, Xuanming Chen,Yuting Yang, Wei Shu, Huaibin Wan, Zheng-Feng Chen, Hong Liang*, Ming Chen*. Latexin deficiency attenuates adipocyte differentiationand protects mice against obesity and metabolic disorders induced by high-fatdiet. Cell Death & Disease,2022,13(2): 175 .

15.    Wen-Ying Shen, Chun-Peng Jia, Li-Yi Liao,Liu-Lin Chen, Cheng Hou, Yang-HanLiu, Hong Liang*, Zhen-Feng Chen*. Copper(II) Complexes of HalogenatedQuinoline Schiff Base Derivatives Enabled Cancer Therapy throughGlutathione-Assisted Chemodynamic Therapy and Inhibition of Autophagy Flux.  J.Med. Chem., 2022, 65, 5134-5148.

16.   Ming Jiang, YongChu, Tongfu Yang, Wenjuan Li, Zhenlei Zhang, Hongbin Sun, Hong Liang*, Feng Yang*. Developing a Novel Indium(III) AgentBased on Liposomes to Overcome Cisplatin-Induced Resistance in Breast Cancer byMultitargeting the Tumor Microenvironment Components. J. Med. Chem.,2021, 64, 14587–14602.

17.    Shulong Wang, Jingjin Zhao, Liangliang Zhang*, Chaobang Zhang,Zhidong Qiu, Shulin Zhao*. Yong Huang, Hong Liang*. A Unique Multifunctional Nanoenzyme Tailoredfor Triggering Tumor Microenvironment Activated NIR-II Photoacoustic Imagingand Chemodynamic/Photothermal Combined Therapy. Adv. Healthcare Mater., 2021,2102073.

18.    Juzheng Zhang, Ming Jiang, Shanhe Li, Zhenlei Zhang, Hongbin Sun, FengYang*, Hong Liang*. Developing a Novel Anticancer Gold(III) Agent toIntegrate Chemotherapy and Immunotherapy. J.Med. Chem., 2021,64, 6777–6791.

19.    Ju-Zheng Zhang, Zhen-Lei Zhang, Ming Jiang, Shan-He Li, Hao-LiangYuan, Hong-Bin Sun, Feng Yang*, HongLiang*. Developing a novel gold(III) agent to treat glioma based on theunique properties of apoferritin nanoparticles: inducing lethal autophagy andapoptosis，J. Med. Chem., 2020, 63, 13695–13708.

20.   Noor Shad Gul†,Taj-Malook Khan1†, Yan-Cheng Liu, Muhammad Iqbal Choudhary,Zhen-Feng Chen*, Hong Liang*. Pd(II) and Rh(III) Complexes with Isoquinoline DerivativesInduced Mitochondria-Mediated Apoptotic and Autophagic Cell Death in HepG2Cells, CCS Chem., 2020, 2, 1626–1641.

21.    Xing Lu, Yan-Cheng Liu, Chris Orvig, Hong Liang*, Zhen-Feng Chen*. Discovery of aCopper-Based Mcl‑1 Inhibitor as an Effffective Antitumor Agent, J. Med. Chem., 2020, 63, 9154–9167.

22.   Jiayao Xu, Lina Fang, Ming Shi,Yong Huang*, Lifang Yao, Shulin Zhao*, Liangliang Zhang, Hong Liang*. Apeptide-based four-color fluorescent polydopamine nanoprobe for multiplexedsensing and imaging of proteases in living cells. Chem. Commun., 2019, 55,1651–1654.

23.   Zhen-Lei Zhang, Ping Yu, YiGou, Ju-Zheng Zhang, Shan-He Li, Mei-Ling Cai, Hong-Bin Sun, Feng Yang*, HongLiang*. A novel brain-tumor-inhibiting copper(II) compound based on HSA–cell penetrating peptide conjugate. J. Med. Chem., 2019, 62, 10630–13069.

24.    Ke-Bin Huang, Feng-Yang Wang, Hai-Wen Feng, He-Jiang Luo, YanLong, Tao-Tao Zou*, Albert S.C.Chan, Rong Liu, Hua-Hong Zou, Zhen-Feng Chen*,Yan-Cheng Liu, You-Nian Liu, Hong Liang*.An aminophosphonate ester ligand-containing platinum(ii)complex induces potent immunogenic cell death in vitro and elicits effectiveanti-tumour immune responses in vivo. Chem.Commun., 2019, 55, 13066.

25.    Ke-Bin Huang, Feng-Yang Wang, Xiao-Ming Tang, Hai-Wen Feng,Zhen-Feng Chen*, Yan-Cheng Liu, You-Nian Liu,Hong Liang*. Organometallic Gold(III)Complexes Similar to Tetrahydroisoquinoline Induce ER-Stress-Mediated Apoptosisand Pro-Death Autophagy in A549 Cancer Cells. J.Med. Chem., 2018, 61, 3478-3490.

26.    Bang-Ping Jiang, Li Zhang, Xiao-Lu Guo, Xing-Can Shen*, Yan Wang,Yang Zhu, Hong Liang*. Poly(N-phenylglycine)-BasedNanoparticles as Highly Effective and Targeted Near-Infrared PhotothermalTherapy/Photodynamic Therapeutic Agents for Malignant Melanoma. Small, 2017, 13, 1602496.

27.    Zhen-Feng Chen*, Qi-Pin Qin, Jiao-Lan Qin, Jie Zhou, Yu-Lan Li, NanLi, Yan-Cheng Liu, Hong Liang*. Water-solubleruthenium(II) complexes with chiral 4-(2,3-Dihydroxypropyl)-formamideoxoaporphine (FOA): in vitro and in vivo anticancer activity by stabilizationof G-Quadruplex DNA, inhibition of telomerase activity, and induction of tumorcell apoptosis. J. Med. Chem. 2015, 58, 4771–4789.

28.    Zhen-Feng Chen*, Qi-Pin Qin, Jiao-Lan Qin, Yan-Cheng Liu, Ke-BinHuang, Yu-Lan Li, Ting Meng, Guo-Hai Zhang, Yan Peng, Xu-Jian Luo, Hong Liang*.  Stabilization of G-quadruplex DNA, inhibitionof telomerase activity, and tumor cell apoptosis by organoplatinum(II)complexes with oxoisoaporphine. J.Med. Chem.,2015, 58, 2159–2179.

29.    Ming-Hua Zeng*, Min-XiaYao, Hong Liang*, Wei-XiongZhang, Xiao-MingChen. A Single-Molecule-Magnetic,Cubane-Based, Triangular Co12 Supercluster. Angew. Chem.Int. Ed., 2007, 46, 1832–1835.

30.   Yi Gou*, Li Liu, Hong Liang*. Editorial on the Research Topic: The Developments of Metal-Based Agents Against LungCancer. Front Pharmacol., 2022, 13, 1101890.